African Trypanosomiasis (Sleeping Sickness)
Human African trypanosomiasis, or “sleeping sickness”, is a parasitic disease of humans and other animals. Untreated, the disease is fatal.
CERID’s research on African Trypanosomiasis is focused on drug discovery & development.
Besnoitiosis is caused by infection with protozoan Besnoitia spp., which are cyst-forming coccidian parasites that affect multiple host species worldwide.
CERID’s work with Besnoitiosis is focused on drug discovery and development.
Chagas disease, or “American trypanosomiasis”, is a tropical parasitic disease caused by the protozoan Trypanosoma cruzi.
Chagas disease research at CERID is focused on drug discovery/development.
Cryptosporidiosis, also known as “Crypto”, is a parasitic disease caused by Cryptosporidium, a microscopic protozoan parasite.
CERID’s work on Cryptosporidiosis focuses on target-based drug discovery and development.
Cystoisosporiasis is an intestinal disease of humans caused by the coccidian parasite Cystoisospora belli.
CERID’s work on Cystoisosporiasis focuses on target-based drug discovery and development.
Giardiasis is a diarrheal illness caused by Giardia, a microscopic parasite found on surfaces or in soil, food or water.
CERID’s work on Giardiasis focuses on target-based drug discovery and development.
Leishmaniasis is a parasitic disease caused by protozoan parasites and is transmitted by the bite of a certain species of sand fly.
CERID’s research concentrates on drug discovery for Leishmania species (the cause of leishmaniasis).
Malaria is a mosquito-borne infectious disease of humans and other animals caused by the parasite Plasmodium.
CERID’s research on Malaria includes immunology, diagnostics and clinical trials to test new drugs and vaccines.
Neosporosis is a disease caused by Neospora caninum, a microscopic protozoan parasite with worldwide distribution.
Theileria parva is a highly pathogenic tick-borne intracellular protozoan parasite of cattle.
CERID is performing proof-of-principle experiments in mice testing a rapid synthetic “minigene” technology for highly parallel synthesis of multi-antigen DNA vaccines, an approach that could support discovery of vaccine subunits.